Altered fibroblast proteoglycan production in COPD
Open Access
- 11 May 2010
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 55
Abstract
Airway remodeling in COPD includes reorganization of the extracellular matrix. Proteoglycans play a crucial role in this process as regulators of the integrity of the extracellular matrix. Altered proteoglycan immunostaining has been demonstrated in COPD lungs and this has been suggested to contribute to the pathogenesis. The major cell type responsible for production and maintenance of ECM constituents, such as proteoglycans, are fibroblasts. Interestingly, it has been proposed that central airways and alveolar lung parenchyma contain distinct fibroblast populations. This study explores the hypothesis that altered depositions of proteoglycans in COPD lungs, and in particular versican and perlecan, is a result of dysregulated fibroblast proteoglycan production. Proliferation, proteoglycan production and the response to TGF-β1 were examined in vitro in centrally and distally derived fibroblasts isolated from COPD patients (GOLD stage IV) and from control subjects. Phenotypically different fibroblast populations were identified in central airways and in the lung parenchyma. Versican production was higher in distal fibroblasts from COPD patients than from control subjects (p < 0.01). In addition, perlecan production was lower in centrally derived fibroblasts from COPD patients than from control subjects (p < 0.01). TGF-β1 triggered similar increases in proteoglycan production in distally derived fibroblasts from COPD patients and control subjects. In contrast, centrally derived fibroblasts from COPD patients were less responsive to TGF-β1 than those from control subjects. The results show that fibroblasts from COPD patients have alterations in proteoglycan production that may contribute to disease development. Distally derived fibroblasts from COPD patients have enhanced production of versican that may have a negative influence on the elastic recoil. In addition, a lower perlecan production in centrally derived fibroblasts from COPD patients may indicate alterations in bronchial basement membrane integrity in severe COPD.Keywords
This publication has 38 references indexed in Scilit:
- Human Lung Parenchyma but Not Proximal Bronchi Produces Fibroblasts with Enhanced TGF-β Signaling and α-SMA ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary diseaseRespiratory Research, 2008
- Regional Fibroblast Heterogeneity in the LungAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2004
- TGF‐β signaling and the fibrotic responseThe FASEB Journal, 2004
- Chronic obstructive pulmonary disease: molecular and cellularmechanismsEuropean Respiratory Journal, 2003
- Quantitative Assessment of Airway Remodeling Using High-Resolution CT*Chest, 2002
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Cartilaginous Airway Dimensions and Airflow Obstruction in Human LungsAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Elastin content of normal and emphysematous lung parenchymaThe American Journal of Medicine, 1980